Endexx Corp. has announced that its HYLA team has secured a distribution agreement and purchase order contract for the sale of its vape products in Egypt.
The provider of innovative, plant-based, and sustainable health and skincare products said the contract exceeds US$1 million for the next 12 months, with an opening order of US$200,000.
“HYLA continues to rapidly expand in multiple international markets as demand for non-nicotine vape alternatives by Hyla continue to fill a major demand void and vacuum in the market,” Endexx CEO Todd Davis said in a statement.
READ: Endexx reports 17% increase in 1Q revenues on higher CBD wellness and Skincare sales
“Better Products, Better You, Endexx continues to provide the best products that fit our motto for the past 10 years, and HYLA products are proving to exceed expectations,” he added.
Vape products are growing at an annual rate of 15% with over $370 million in e-cigarettes revenues in 2022, according to the company.
Endexx noted that Hyla products are anticipated to be a well-received product in this market offering an alternative to nicotine-based products.
Endexx develops and distributes all-natural, plant-derived topical skincare products. Its products vary from balms, creams, lotions, butters, masks, scrubs, and oils, all with the shared purpose of healthy skin and grooming wellness.
The science behind these products involves a decade of clinical research in the field and lab work to provide a functional formulation with ingredients for optimal absorption and support of skin health.
Contact Sean at sean@proactiveinvestors.com